Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers

Mehmet Sofuoglu; Maria Mouratidis; Marc E Mooney

doi:10.1016/j.psyneuen.2010.07.005

Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers

Mehmet Sofuoglu, Maria Mouratidis, Marc E Mooney

Psychology (Twin Cities)

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Abstract

Background: Progesterone, a steroid hormone, has been implicated in many CNS functions including reward, cognition, and neuroprotection. The goal of this study was to examine the dose-dependent effects of progesterone on cognitive performance, smoking urges, and smoking behavior in smokers. Methods: Thirty female and thirty-four male smokers participated in a double-blind, placebo-controlled study. Female smokers were in the early follicular phase of their menstrual cycle during study participation. Smokers were randomly assigned to either 200 or 400. mg/day of progesterone or placebo, given in two separate doses, during clinic visit. The first 3 days of the treatment period, smokers abstained from smoking, which was verified with breath CO levels. Smokers attended an experimental session on day 4 where the number of cigarettes smoked were recorded starting 2. h after the medication treatment. Results: Progesterone treatment, 200. mg/day, significantly improved cognitive performance in the Stroop and the Digit Symbol Substitution Test. Progesterone at 400. mg/day was associated with reduced urges for smoking but did not change ad lib smoking behavior. Conclusions: These findings suggest a potential therapeutic value of progesterone for smoking cessation.

Original language	English (US)
Pages (from-to)	123-132
Number of pages	10
Journal	Psychoneuroendocrinology
Volume	36
Issue number	1
DOIs	https://doi.org/10.1016/j.psyneuen.2010.07.005
State	Published - Jan 2011

Bibliographical note

Funding Information:
Dr. Mooney has received research grants from Pfizer Corporation. The remaining authors have no conflicts of interest to declare.

Funding Information:
This research was supported by the Veterans Administration Mental Illness Research, Education and Clinical Center (MIRECC) and the National Institute on Drug Abuse (NIDA) grants R01-DA 14537, K02-DA021304 (MS) and K01-DA-019446 (MM). The funding agencies had no further role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.

Keywords

Cognitive performance
Menstrual cycle phase
Nicotine dependence
Progesterone
Sex differences

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.psyneuen.2010.07.005

Find It

Find It at U of M Libraries

Cite this

@article{6d82cb2ee25e4fffa3033689f0768f77,

title = "Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers",

abstract = "Background: Progesterone, a steroid hormone, has been implicated in many CNS functions including reward, cognition, and neuroprotection. The goal of this study was to examine the dose-dependent effects of progesterone on cognitive performance, smoking urges, and smoking behavior in smokers. Methods: Thirty female and thirty-four male smokers participated in a double-blind, placebo-controlled study. Female smokers were in the early follicular phase of their menstrual cycle during study participation. Smokers were randomly assigned to either 200 or 400. mg/day of progesterone or placebo, given in two separate doses, during clinic visit. The first 3 days of the treatment period, smokers abstained from smoking, which was verified with breath CO levels. Smokers attended an experimental session on day 4 where the number of cigarettes smoked were recorded starting 2. h after the medication treatment. Results: Progesterone treatment, 200. mg/day, significantly improved cognitive performance in the Stroop and the Digit Symbol Substitution Test. Progesterone at 400. mg/day was associated with reduced urges for smoking but did not change ad lib smoking behavior. Conclusions: These findings suggest a potential therapeutic value of progesterone for smoking cessation.",

keywords = "Cognitive performance, Menstrual cycle phase, Nicotine dependence, Progesterone, Sex differences",

author = "Mehmet Sofuoglu and Maria Mouratidis and Mooney, {Marc E}",

note = "Funding Information: Dr. Mooney has received research grants from Pfizer Corporation. The remaining authors have no conflicts of interest to declare. Funding Information: This research was supported by the Veterans Administration Mental Illness Research, Education and Clinical Center (MIRECC) and the National Institute on Drug Abuse (NIDA) grants R01-DA 14537, K02-DA021304 (MS) and K01-DA-019446 (MM). The funding agencies had no further role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication. ",

year = "2011",

month = jan,

doi = "10.1016/j.psyneuen.2010.07.005",

language = "English (US)",

volume = "36",

pages = "123--132",

journal = "Psychoneuroendocrinology",

issn = "0306-4530",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers

AU - Sofuoglu, Mehmet

AU - Mouratidis, Maria

AU - Mooney, Marc E

N1 - Funding Information: Dr. Mooney has received research grants from Pfizer Corporation. The remaining authors have no conflicts of interest to declare. Funding Information: This research was supported by the Veterans Administration Mental Illness Research, Education and Clinical Center (MIRECC) and the National Institute on Drug Abuse (NIDA) grants R01-DA 14537, K02-DA021304 (MS) and K01-DA-019446 (MM). The funding agencies had no further role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.

PY - 2011/1

Y1 - 2011/1

N2 - Background: Progesterone, a steroid hormone, has been implicated in many CNS functions including reward, cognition, and neuroprotection. The goal of this study was to examine the dose-dependent effects of progesterone on cognitive performance, smoking urges, and smoking behavior in smokers. Methods: Thirty female and thirty-four male smokers participated in a double-blind, placebo-controlled study. Female smokers were in the early follicular phase of their menstrual cycle during study participation. Smokers were randomly assigned to either 200 or 400. mg/day of progesterone or placebo, given in two separate doses, during clinic visit. The first 3 days of the treatment period, smokers abstained from smoking, which was verified with breath CO levels. Smokers attended an experimental session on day 4 where the number of cigarettes smoked were recorded starting 2. h after the medication treatment. Results: Progesterone treatment, 200. mg/day, significantly improved cognitive performance in the Stroop and the Digit Symbol Substitution Test. Progesterone at 400. mg/day was associated with reduced urges for smoking but did not change ad lib smoking behavior. Conclusions: These findings suggest a potential therapeutic value of progesterone for smoking cessation.

AB - Background: Progesterone, a steroid hormone, has been implicated in many CNS functions including reward, cognition, and neuroprotection. The goal of this study was to examine the dose-dependent effects of progesterone on cognitive performance, smoking urges, and smoking behavior in smokers. Methods: Thirty female and thirty-four male smokers participated in a double-blind, placebo-controlled study. Female smokers were in the early follicular phase of their menstrual cycle during study participation. Smokers were randomly assigned to either 200 or 400. mg/day of progesterone or placebo, given in two separate doses, during clinic visit. The first 3 days of the treatment period, smokers abstained from smoking, which was verified with breath CO levels. Smokers attended an experimental session on day 4 where the number of cigarettes smoked were recorded starting 2. h after the medication treatment. Results: Progesterone treatment, 200. mg/day, significantly improved cognitive performance in the Stroop and the Digit Symbol Substitution Test. Progesterone at 400. mg/day was associated with reduced urges for smoking but did not change ad lib smoking behavior. Conclusions: These findings suggest a potential therapeutic value of progesterone for smoking cessation.

KW - Cognitive performance

KW - Menstrual cycle phase

KW - Nicotine dependence

KW - Progesterone

KW - Sex differences

UR - http://www.scopus.com/inward/record.url?scp=78649894217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649894217&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2010.07.005

DO - 10.1016/j.psyneuen.2010.07.005

M3 - Article

C2 - 20675057

AN - SCOPUS:78649894217

VL - 36

SP - 123

EP - 132

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 1

ER -

Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this